Background: Cataracts are a common and significant cause of visual impairment globally. We aimed to evaluate\r\nuncorrected distance visual acuity (UDVA) as an outcome in treating astigmatic cataract patients to assist clinicians\r\nor ophthalmologists in their decision making process regarding available interventions.\r\nMethods: Medline, Embase and Evidence Based Reviews were systematically reviewed to identify relevant studies\r\nreporting changes in UDVA, UIVA and UNVA after cataract surgery in presbyopic patients. Strict inclusion/exclusion\r\ncriteria were used to exclude any non-relevant studies. Relevant outcomes (UDVA, UIVA and UNVA) were identified\r\nfrom the studies retrieved through the systematic review process.\r\nResults: The systematic review identified 11 studies which reported UCVA. All 11 studies reported UDVA. Four\r\nbrands of toric intraocular lenses (IOLs) were reported in these studies. All studies identified in the literature search\r\nreported improvements in UDVA following surgical implant of a toric IOL. The largest improvements in VA were\r\nreported using the Human Optics MicroSil toric IOL (0.74 LogMAR, UDVA) and the smallest improvements were also\r\nreported using the Human Optics MicroSil toric IOL (0.23 LogMAR, UDVA) in a different study.\r\nConclusions: The results of this systematic review showed the aggregate of studies reporting a beneficial increase\r\nin UDVA with the use of toric IOLs in cataract patients with astigmatism.
Loading....